Supplementary Information (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Foreign Currency Exchange Gain (Loss)

	For the Year Ended December 31,
(In millions)	2025		2024		2023
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss)	$	(254)	$	(152)	$	(371)
Local tax (expenses) benefits	11		11		55
Net after-tax impact from subsidiary exchange gain (loss)	$	(243)	$	(141)	$	(316)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	73	$	(132)	$	(26)
Tax (expenses) benefits	(8)		26		7
Net after-tax impact from hedging program exchange gain (loss)	$	65	$	(106)	$	(19)
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	(181)	$	(284)	$	(397)
Tax (expenses) benefits	3		37		62
Net after-tax exchange gain (loss)	$	(178)	$	(247)	$	(335)
Noncontrolling interest adjustment	—		1		—
Net after-tax exchange gain (loss) attributable to Corteva	$	(178)	$	(246)	$	(335)

Restrictions on Cash and Cash Equivalents

(In millions)	December 31, 2025		December 31, 2024
Cash and cash equivalents	$	4,521	$	3,106
Restricted cash equivalents	204		316
Total cash, cash equivalents and restricted cash equivalents	$	4,725	$	3,422

Schedule of Other Nonoperating Income (Expense)

Other Income (Expense) - Net	For the Year Ended December 31,
(In millions)	2025		2024		2023
Interest income	$	136	$	132	$	283
Equity in earnings (losses) of affiliates - net	13		15		10
Net gain (loss) on sales of businesses and other assets	41		17		22
Net exchange gains (losses) 1	(181)		(284)		(397)
Non-operating pension and other post-employment benefit credits (costs) 2	(23)		(144)		(119)
Miscellaneous income (expenses) - net 3	(556)		(36)		(247)
Other income (expense) - net	$	(570)	$	(300)	$	(448)

1.    Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.

2.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 

3.    Includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2025 includes a charge related to the Bayer resolution offset by the receipt of insurance proceeds. The year ended December 31, 2024 includes the receipt of insurance proceeds and an indemnification payment negotiated with the prior Stoller owners. The years ended December 31, 2024 and 2023 also include estimated settlement reserves. The year ended December 31, 2023 also includes an Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). See Note 22 - Segment Information, to the Consolidated Financial Statements, for additional information on significant items.